Patent Assignment
Reel/Frame 069259/0699
Assignment of Assignor's Interest
Recorded: 2024-11-14
Pages: 8
Assignor
WELLSTAT THERAPEUTICS CORPORATION
Executed: 2023-06-23
Assignee
BTG INTERNATIONAL INC.
300 FOUR FALLS CORPORATE CENTER, 300 CONSHOHOCKEN STATE ROAD, SUITE 300, WEST CONSHOHOCKEN, DELAWARE, 19428-3820
Covered Property
(1)
Acylated Uridine and Cytidine and Uses Thereof
Patent:
6,258,795 →
Application:
08/466,145 →
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger
Sep 5, 2014
From: WELLSTAT THERAPEUTICS CORPORATION
To: WELLSTAT THERAPEUTICS CORPORATION
Reel/Frame 033674/0573 →
Assignment of Assignor's Interest
Sep 5, 2014
From: VON BORSTEL, REID W.; BAMAT, MICHAEL K.
To: WELLSTAT THERAPEUTICS CORPORATION
Reel/Frame 033674/0729 →
Change of Name
Sep 5, 2014
From: PRO-NEURON, INC.
To: WELLSTAT THERAPEUTICS CORPORATION
Reel/Frame 033692/0660 →
Release of Certain Intellectual Property Collateral Owned by Wellstat Therapeutics Corporation Recorded at Reel 031227/Frame 0227
Jun 30, 2023
From: PDL BIOPHARMA, INC.
To: WELLSTAT THERAPEUTICS CORPORATION
Reel/Frame 064180/0456 →